1st Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S 2948 Medicaid Generic Drug Price Fainess Act H.R.1353 PATIENT Act of 2015 Lobbied on issues related to abuse deterrent formulations of drugs and prescription drug abuse FDA proposed rule on generic drug labels
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | special assistant to the President 2002-2005 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.